Otonomy Announces Pricing of Public Offering of Common Stock

Back to Jobs

SAN DIEGO , Jan. 06, 2016 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ:OTIC), a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear, today announced the pricing of an underwritten public offering of 5,000,000

Apply Now